Drug-Related Side Effects and Adverse Reactions

Displaying 1 - 14 of 14CSV
Wu, W., Jin, Q., Östlund, C., Tanji, K., Shin, J.-Y., Han, J., Leu, C.-S., Kushner, J., & Worman, H. J. (2024). mTOR Inhibition Prolongs Survival and Has Beneficial Effects on Heart Function After Onset of Lamin A/C Gene Mutation Cardiomyopathy in Mice. Circulation: Heart Failure, 17(4). https://doi.org/10.1161/circheartfailure.123.011110
Publication Date
Gauffin, O., Brand, J. S., Vidlin, S. H., Sartori, D., Asikainen, S., Català, M., Chalabi, E., Dedman, D., Danilovic, A., Duarte-Salles, T., García Morales, M. T., Hiltunen, S., Jödicke, A. M., Lazarevic, M., Mayer, M. A., Miladinovic, J., Mitchell, J., Pistillo, A., Ramírez-Anguita, J. M., … Norén, G. N. (2023). Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study. Drug Safety, 46(12), 1335–1352. https://doi.org/10.1007/s40264-023-01353-w
Publication Date
Patel, D., Sorkin, B. C., Mitchell, C. A., Embry, M. R., Rina-Kong, S., Adams, R. E., DeTemple, E. R., Reddam, A., Gafner, S., Kelber, O., Rider, C. V., Oketch-Rabah, H., Roe, A. L., Marles, R. J., Dever, J., & Dentali, S. (2023). Improving the rigor and utility of botanical toxicity studies: Recommended resources. Regulatory Toxicology and Pharmacology, 144, 105471. https://doi.org/10.1016/j.yrtph.2023.105471
Publication Date
Tardelli, V., Xu, K. Y., Bisaga, A., Levin, F. R., Fidalgo, T. M., & Grucza, R. A. (2023). Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention and overdose risk. BMJ Mental Health, 26(1), e300728. https://doi.org/10.1136/bmjment-2023-300728
Publication Date
Michel, A., Lee, R. T., Salehi, E., & Accordino, M. K. (2023). Improving Quality of Life During Chemotherapy: Cannabinoids, Cryotherapy, and Scalp Cooling. American Society of Clinical Oncology Educational Book, 43. https://doi.org/10.1200/edbk_390428
Publication Date
Shah, J., Muir, J., Furfaro, D., Beitler, J. R., & Dzierba, A. L. (2021). Use of N-Acetylcysteine for Clozapine-Induced Acute Liver Injury: A Case Report and Literature Review. Journal of Pharmacy Practice, 36(2), 463–467. https://doi.org/10.1177/08971900211034007
Publication Date
Park, K., Sabari, J. K., Haura, E. B., Shu, C. A., Spira, A., Salgia, R., Reckamp, K. L., Sanborn, R. E., Govindan, R., Bauml, J. M., Curtin, J. C., Xie, J., Roshak, A., Lorenzini, P., Millington, D., Thayu, M., Knoblauch, R. E., & Cho, B. C. (2023). Management of infusion-related reactions (IRRs) in patients receiving amivantamab in the CHRYSALIS study. Lung Cancer, 178, 166–171. https://doi.org/10.1016/j.lungcan.2023.02.008
Publication Date
Hernández-Calle, D., Martínez-Alés, G., & López-Cuadrado, T. (2022). Suicidal and accidental drug poisoning mortality among older adults and working-age individuals in Spain between 2000 and 2018. BMC Geriatrics, 22(1). https://doi.org/10.1186/s12877-022-02806-0
Publication Date
Columbia Affiliation
Capaccione, K. M., Valiplackal, J. P., Huang, A., Roa, T., Fruauff, A., Liou, C., Kim, E., Khurana, S., Maher, M., Ma, H., Ngyuen, P., Mak, S., Dumeer, S., Lala, S., D’souza, B., Laifer-Narin, S., Desperito, E., Ruzal-Shapiro, C., & Salvatore, M. M. (2022). Checkpoint Inhibitor Immune-Related Adverse Events: A Multimodality Pictorial Review. Academic Radiology, 29(12), 1869–1884. https://doi.org/10.1016/j.acra.2022.03.007
Publication Date
Yeboah-Korang, A., Memon, A., Patel, N., Portocarrero-Castillo, A., Osman, A., Kleesattel, D., Lopez, C., Louissaint, J., Sherman, K., & Fontana, R. (2022). Impact of Prior Drug Allergies on the Risk, Clinical Features, and Outcomes of Idiosyncratic Drug-Induced Liver Injury in Adults. Digestive Diseases and Sciences, 67(11), 5262–5271. https://doi.org/10.1007/s10620-022-07403-0
Publication Date
Campbell, C., McCormack, M., Patel, S., Stapleton, C., Bobbili, D., Krause, R., Depondt, C., Sills, G. J., Koeleman, B. P., Striano, P., Zara, F., Sander, J. W., Lerche, H., Kunz, W. S., Stefansson, K., Stefansson, H., Doherty, C. P., Heinzen, E. L., Scheffer, I. E., … Cavalleri, G. L. (2022). A pharmacogenomic assessment of psychiatric adverse drug reactions to levetiracetam. Epilepsia, 63(6), 1563–1570. Portico. https://doi.org/10.1111/epi.17228
Publication Date
Columbia Affiliation